RVXCF
RESVERLOGIX CORP by Resverlogix Corp. (RVXCF)
$06
About RESVERLOGIX CORP by Resverlogix Corp. (RVXCF)
Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan, and Alzheimer's diseases. The company was founded by Donald J. McCaffrey and Norman C. W. Wong on August 17, 2000 and is headquartered in Calgary, Canada.
Details
Daily high
$0.06
Daily low
$0.06
Price at open
$0.06
52 Week High
$0.21
52 Week Low
$0.02
Market cap
16.3M
Dividend yield
0.00%
Volume
2,050
Avg. volume
25,651
P/E ratio
-2.27
RESVERLOGIX CORP by Resverlogix Corp. News
Details
Daily high
$0.06
Daily low
$0.06
Price at open
$0.06
52 Week High
$0.21
52 Week Low
$0.02
Market cap
16.3M
Dividend yield
0.00%
Volume
2,050
Avg. volume
25,651
P/E ratio
-2.27